Neurodegenerative Diseases of the Retina and Potential for Protection and Recovery
Author Information
Author(s): Schmidt K.-G, Bergert H, Funk R.H.W
Primary Institution: Department of Ophthalmology, Starnberg, Germany
Hypothesis
Can neuroprotective agents prevent retinal neuron death caused by metabolic stress in neurodegenerative diseases?
Conclusion
Several drugs can reduce or prevent the death of retinal neurons by blocking NMDA receptors and mitigating metabolic stress.
Supporting Evidence
- Retinal ganglion cells are particularly vulnerable to metabolic stress.
- Blocking NMDA receptors can prevent neuronal death in the retina.
- Advanced glycation endproducts contribute to retinal cell dysfunction.
Takeaway
This study talks about how certain diseases can harm the cells in our eyes, but some medicines might help protect those cells and keep them healthy.
Methodology
The review discusses various experimental studies on neuroprotection in retinal diseases.
Limitations
The review primarily focuses on experimental studies, which may not fully translate to clinical settings.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website